Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study

References

• Turner MR, Swash M. The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey. J Neurol Neurosurg Psychiatry. 2015;86:667–73.
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86:168–73.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;5:1–22.
   Google Scholar
• Devenney E, Vucic S, Hodges JR, Kiernan MC. Motor neuron disease-frontotemporal dementia: a clinical continuum. Expert Rev Neurother. 2015;15:509–22.
   PubMed Web of Science ®Google Scholar
• Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263–9.
   PubMed Web of Science ®Google Scholar
• Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005;65:1774–7.
   PubMed Web of Science ®Google Scholar
• EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis; Andersen PM, Abrahams S, Borasio GD, Carvalho Md, Chio A, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revisedreport of an EFNS task force. Eur J Neurol. 2012;19:360–75.
   PubMed Web of Science ®Google Scholar
• Caga J, Hsieh S, Lillo P, Dudley K, Mioshi E. The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Front Neurol. 2019;10:192.
   PubMed Web of Science ®Google Scholar
• Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80:1590–7.
   PubMed Web of Science ®Google Scholar
• Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 2018;91:e1370–80.
   PubMed Web of Science ®Google Scholar
• Chiò A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population based cohort. Neurology. 2019;93:e984–94.
   PubMed Web of Science ®Google Scholar
• Trojsi F, Santangelo G, Caiazzo G, Siciliano M, Ferrantino T, Piccirillo G, et al. Neuropsychological assessment in different King’s clinical stages of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:228–35.
   PubMed Web of Science ®Google Scholar
• Woolley SC, Rush BK. Considerations for clinical neuropsychological evaluation in amyotrophic lateral sclerosis. Arch Clin Neuropsychol. 2017;32:906–16.
   PubMed Web of Science ®Google Scholar
• Kilani M, Micallef J, Soubrouillard C, Rey-Lardiller D, Dematteï C, Dib M, et al. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:46–54.
   PubMed Web of Science ®Google Scholar
• Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, Graf M, Uttner I, Muche R, et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol. 2005;252:772–81.
   PubMed Web of Science ®Google Scholar
• Kasper E, Zydatiss K, Schuster C, Machts J, Bittner D, Kaufmann J, et al. No change in executive performance in ALS Patients: a longitudinal neuropsychological study. Neurodegener Dis. 2016;16:184–91.
   PubMed Web of Science ®Google Scholar
• Simon N, Goldstein LH. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:1–11.
   PubMed Web of Science ®Google Scholar
• Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, et al. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:387–95.
   PubMed Web of Science ®Google Scholar
• Bock M, Duong Y-N, Kim A, Allen I, Murphy J, Lomen-Hoerth C, et al. Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurol Clin Pract. 2017;7:488–98.
   PubMedGoogle Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. The Awaji criteria for diagnosis of ALS. Muscle Nerve. 2011;44:456–7.
   PubMed Web of Science ®Google Scholar
• Terrera GM, Minett T, Brayne C, Matthews FE. Education associated with a delayed onset of terminal decline. Age Ageing. 2014;43:26–31.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRSR: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Basso A, Capitani E, Laiacona M. Raven’s coloured progressive matrices: normative values on 305 adult normative controls. Funct Neurol. 1987;2:189–94.
   PubMedGoogle Scholar
• Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, et al. Clock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37:725–9.
   PubMed Web of Science ®Google Scholar
• Della Sala S, MacPherson SE, Phillips LH, Sacco L, Spinnler H. How many camels are there in Italy? Cognitive estimates standardised on the Italian population. Neurol Sci. 2003;24:10–5.
   PubMed Web of Science ®Google Scholar
• Iavarone A, et al. The Frontal Assessment Battery (FAB): normative data from an Italian sample and performances of patients with Alzheimer’s disease and frontotemporal dementia. Funct Neurol. 2004;19:191–6.
   PubMed Web of Science ®Google Scholar
• Van Gorp WG, Satz P, Kiersch ME, Henry R. Normative data on the boston Naming Test for a group of normal older adults. J Clin Exp Neuropsychol. 1986;8:702–5.
   PubMed Web of Science ®Google Scholar
• Spinnler H, Tognoni G. Standardizzazione taratura italiana dei test neuropsicologici. Italian J Neurol Sci. 1987;8:1–120.
   PubMedGoogle Scholar
• Novelli G, Papagno C, Capitani E, et al. Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali (normative values of three tests of lexical production). Archivio di Psicologia Neurologia e Psichiatria. 1986;47:477–506.
   Google Scholar
• Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E, et al. Trail Making Test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996;17:305–9.
   PubMedGoogle Scholar
• Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:489–98.
   PubMed Web of Science ®Google Scholar
• Ahn S-W, Kim S-H, Kim J-E, Kim S-M, Kim SH, Sung J-J, et al. Frontal assessment battery to evaluate frontal lobe dysfunction in ALS patients. Can J Neurol Sci. 2011;38:242–6.
   PubMed Web of Science ®Google Scholar
• Grace J, Malloy p. Frontal systems behavior scale (FrSBe): professional manual. Lutz, FL: Psychological Assessment Resources; 2001.
   Google Scholar
• De Marchi F, Sarnelli MF, Solara V, Bersano E, Cantello R, Mazzini L, et al. Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand. 2019;139:438–45.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82.
   PubMed Web of Science ®Google Scholar
• Iazzolino B, Pain D, Peotta L, Calvo A, Moglia C, Canosa A, et al. Validation of the revised classification of cognitive and behavioural impairment in ALS. J Neurol Neurosurg Psychiatry. 2019;90:734–9.
   PubMed Web of Science ®Google Scholar
• Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Lomen-Hoerth C, et al. Longitudinal screening detects cognitive stability and behavioral deterioration in ALS patients. Behav Neurol. 2018;2018:1–7.
   Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
   PubMed Web of Science ®Google Scholar
• Kanouchi T, Ohkubo T, Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation. J Neurol Neurosurg Psychiatry. 2012;83:739–45.
   PubMed Web of Science ®Google Scholar
• Agosta F, Ferraro PM, Riva N, Spinelli EG, Chiò A, Canu E, et al. Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp. 2016;37:1614–26.
   PubMed Web of Science ®Google Scholar
• Agosta F, Spinelli EG, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses. Expert Rev Neurother. 2018;18:395–406.
   PubMed Web of Science ®Google Scholar
• Willekens SMA, Van Weehaeghe D, Van Damme P, Van Laere K. Positron emission tomography in amyotrophic lateral sclerosis: towards targeting of molecular pathological hallmarks. Eur J Nucl Med Mol Imaging. 2017;44:533–47.
   PubMed Web of Science ®Google Scholar
• Lulé D, Böhm S, Müller H-P, Aho-Özhan H, Keller J, Gorges M, et al. Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex. 2018;101:163–71.
   PubMed Web of Science ®Google Scholar
• Poletti B, Carelli L, Solca F, Lafronza A, Pedroli E, Faini A, et al. An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS. J Neurol. 2017;264:1136–45.
   PubMed Web of Science ®Google Scholar
• Carelli L, Solca F, Faini A, Meriggi P, Sangalli D, Cipresso P, et al. Brain-computer interface for clinical purposes: cognitive assessment and rehabilitation. Biomed Res Int. 2017;2017:1695290.
   PubMed Web of Science ®Google Scholar